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Abstract 
Purpose:  To investigate and compare the contrast‑enhanced ultrasound (CEUS) features of histologically proven 
HCA with those of contrast‑enhanced computed tomography (CECT).
Methods: Eighteen patients with proven hepatic adenoma by pathology were retrospectively selected from the 
CEUS database. Fourteen of them had undergone liver CECT exams. The basic features on unenhanced imaging and 
the enhancement level and specific features on contrast‑enhanced imaging were retrospectively analyzed, and the 
differences between CEUS and CECT were compared.
Results: All the HCAs showed hyper‑enhancement in the arterial phase. During the portal and late phases, 12 HCAs 
(12/18, 66.7 %) on CEUS and 11 (11/14, 78.6 %) on CT showed washout. On CEUS, 10 (10/18, 55.5 %) showed cen‑
tripetal filling in the arterial phase and persistent peripheral rim enhancement. Five of them (61.1 %, 11/18) showed 
delayed central washout in the portal or late phase. However, on CECT, 2 (14.3 %, 2/14) and 4 (28.6 %, 4/14) HCAs 
showed persistent enhancement of the peripheral rim and central non‑enhancing hemorrhage areas, respectively.
Conclusions: Compared with dynamic CT, CEUS was superior at characterizing specific dynamic features. Consid‑
ering that it is radiation‑free, readily availability and easy to use, CEUS is suggested as the first line imaging tool to 
diagnose HCA.
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Background
Hepatic adenoma (HCA) is the third most common 
benign hepatic neoplasm. It may undergo malignant 
transformation and has a marked tendency to hemor-
rhage (Laumonier et  al. 2008). The differential diag-
nosis with other focal liver lesions (FLLs), particularly 
focal nodular hyperplasia (FNH) and well-differentiated 
hepatocellular carcinoma (HCC), is of great significance 
because of the different management and outcomes for 
patients (Bartolozzi et al. 1997; Dietrich et al. 2005; Kim 
et al. 2008; Roche et al. 2015; Kong et al. 2015; Lizardi-
Cervera et al. 2006). Therefore, a non-invasive diagnosis 
is beneficial for further treatment.
Because of its broad availability and a faster multi-row 
detector, computed tomography (CT) has become an 
excellent tool for the detection and characterization of 
FLLs. Typical enhancements of HCA on CT are likely to 
be iso-attenuated with the surrounding liver on unen-
hanced CT, becoming hyper-attenuated in the arterial 
phase and then fading to iso-/hypo-attenuation in the 
portal or late phase (Hussain et al. 2006; Ichikawa et al. 
2000). Hemorrhage and calcification in HCA are present 
at low sensitivities of 9–15.7 and 5–15  %, respectively 
(Hussain et al. 2006; Ichikawa et al. 2000). However, these 
imaging features are not specific to the diagnosis of HCA 
(Ronot and Vilgrain 2014). Furthermore, considering the 
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radiation hazard, characterization of HCA using CT is a 
questionable practice.
Contrast-enhanced ultrasound (CEUS) has provided a 
real-time technique to delineate lesions (Bartolotta et al. 
2009). It is believed that CEUS can depict more morpho-
logic features of FLLs owing to its high spatial and tem-
poral resolution (Wang et al. 2013; Claudon et al. 2013). 
On CEUS, in addition to centripetal enhancement in the 
arterial phase, persistent peripheral rim enhancement 
and delayed central washout are also reported as specific 
dynamic features for the characterization of HCA (Kong 
et al. 2015; Roche et al. 2015). Because CEUS is radiation-
free, readily available and easy to use, many centers have 
employed CEUS as a routine part of their work-up of 
FLLs (Jung et al. 2007).
To date, many studies have focused on the differential 
diagnosis of HCA and FNH using CEUS (Dietrich et al. 
2005; Kim et  al. 2008; Kong et  al. 2015). However, few 
studies have compared the characteristics of HCA on 
CEUS with those on dynamic CT. The purpose of our 
study was to compare the CEUS features of histologically 
proven HCA with those of CT.
Methods
Patient population
This retrospective study was approved by the ethics 
committee of the first and third hospital of Sun Yat-Sen 
University, and informed consent was obtained from all 
subjects. From June 2008 to October 2015, 18 patients 
(9 men and 9 women; mean age ± SD, 33 years ± 8; age 
range 18–52  years) were histologically proven to have 
hepatic adenoma and were retrospectively selected from 
our database. The pathological diagnosis was obtained by 
specimens from ultrasound-guided percutaneous biopsy 
(n = 2) or surgical resection (n = 16). Fourteen patients 
had undergone a dynamic CT of the liver. Their basic 
characteristics are presented in Table 1.
CEUS techniques
All examinations were performed using the Aplio XV or 
500 (Toshiba Medical Systems, Tokyo, Japan), equipped 
with a 375BT convex transducer (frequency range of 1.9–
6.0 MHz), or the MyLab Twice (Esaote Medical Systems, 
Genoa, Italy), equipped with a CA541 convex transducer 
(frequency range of 1.0–8.0 MHz). The contrast-specific 
imaging modes used in the present study were contrast 
harmonic imaging (MI, 0.06–0.08) and contrast tuned 
imaging (MI, 0.06–0.10). After activation of the con-
trast mode, 2.4  ml of SonoVue (Bracco, Milan, Italy) 
were administered intravenously in a bolus fashion and 
flushed by 5 ml of 0.9 % saline solution. The target lesion 
was observed continuously for 6 min, and the entire arte-
rial, portal and late phases were stored on the hard disk. 
The arterial, portal and late phases were defined as 0–30, 
31–120 and 121–360  s after injection, respectively. All 
the CEUS examinations were performed by two experi-
enced radiologists (W.W. and X.Y.X), both of whom had 
more than 8 years of experience in liver CEUS.
CT techniques
Among 18 HCAs, 14 were analyzed with CT (Aquilion 
64, Toshiba Medical System, Tokyo, Japan) within 
2 weeks before or after the CEUS examination. The stand-
ard dynamic contrast-enhanced scan procedure is as fol-
lows: After an unenhanced helical sequence scan through 
the liver, 80–100  ml (1.5  ml/kg) of a contrast agent 
(Ultravist 300, Schering, Berlin, Germany) were admin-
istered via the antecubital vein at a rate of 3–4 ml/s. The 
following CT acquisition parameters were used: 120 kV; 
200–250 mAs; collimation: 64 mm × 0.5 mm; slice thick-
ness: 0.5  mm; slice increments: 0.5  mm; and pitch: 0.9. 
The arterial, portal and late phases were defined as 0–45, 
46–120 and 121–360 s after injection, respectively.
Image analysis
CEUS and dynamic CT images were retrospectively 
analyzed in consensus by two investigators (Z.W. and 
L.D.C.), both of whom had more than 6 years of experi-
ence evaluating liver imaging. They were not involved in 
the US or CT scanning and were unaware of the clinical 
and imaging information of the patients. The enhance-
ment level of each phase and specific enhancement 
pattern were evaluated. The level of enhancement was 
subdivided into hypo-enhancement, iso-enhancement, 
and hyper-enhancement compared with the surrounding 
liver parenchyma. Centripetal filling was defined as rapid 
centripetal progression of the enhancement in the arte-
rial phase. Persistent peripheral rim enhancement was 
defined as persistent hyper-echogenicity at the rim of 
the lesion in the arterial, portal and late phases. Central 
washout was defined as hypo-enhancement in the center 
of the lesion compared with the peripheral region (Clau-
don et al. 2013).
Statistical analysis
The statistical analysis was performed using SPSS 16.0 
software (SPSS Inc., Chicago, IL, USA). Data were pre-
sented as the mean ±  standard deviation (SD). P < 0.05 
was considered to indicate statistical significance. The 
detection rate of imaging features between CEUS and 
dynamic CT was assessed using χ2 or Fisher’s exact test.
Results
Basic features on unenhanced imaging
There were 6 (6/18, 33.3 %); 9 (9/18, 50.0 %); and 3 (3/18, 
16.7  %) lesions located in the left, right and both lobes 
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of the liver, respectively. The mean size of the lesions 
was 8.4  ±  5.5  cm (range 1.4–20  cm). All lesions were 
round shaped with clear boundary. On gray scale ultra-
sonography, 9 of 18 lesions (9/18, 50.0  %) appeared 
hypoechoic to the background liver parenchyma, and 
6 (6/18, 33.3  %); 2 (2/18, 11.1  %); and 1 (1/18, 5.6  %) 
lesions appeared hyperechoic, isoechoic and mixechoic, 
respectively. On color Doppler, a short, rod-like flow 
pattern in HCAs or periphery vessels of the lesions 
was detected (8/18, 44.4  %). On the CT scan, 12 of 14 
lesions (85.7  %) appeared hypo-attenuated to the back-
ground liver parenchyma, and only 1 lesion (1/8, 12.5 %) 
appeared hyper-, iso- and mix-attenuated, respectively 
(Table 1).
Table 1 Patient characteristics
CEUS contrast-enhanced ultrasound, Hype hyper-enhancement, Iso iso-enhancement, Hypo hypo-enhancement
Case No. Age Gender Location Diameter (cm) US CT CEUS patterns Dynamic CT patterns
1 37 F S7 2.0 Iso Hypo Hype‑Hype‑Hype Hype‑Iso‑Iso
2 30 F S6.7 9.9 Hypo Hypo Hype‑Hypo‑Hypo Hype‑Hypo‑Hypo
3 41 M S6.7 5.4 Hypo Hypo Hype‑Hypo‑Hypo Hyper‑Iso‑Iso
4 29 F S5.6.7.8 17.2 Hype Hypo Hype‑Hypo‑Hypo Hype‑Hypo‑Hypo
5 22 F S4.5.8 20.0 Hypo Hype Hype‑Iso‑Hypo Hype‑Hype‑Hype
6 35 F S4 6.7 Hype Hypo Hype‑Iso‑Hypo Hype‑Hypo‑Hypo
7 31 M S4.8 5.5 Hypo Hypo Hype‑Iso‑Hypo Hype‑Iso‑Hypo
8 26 F S4 8.0 Hypo Hypo Hype‑Iso‑Iso Hype‑Hypo‑Hypo
9 31 F S2.3 1.4 Hypo Hype‑Iso‑Iso
10 45 F S4 8.3 Hypo Hype‑Hypo‑Hypo
11 29 F S6 18.0 Hypo Hypo Hype‑Iso‑Iso Hype‑Hypo‑Hypo
12 38 M S7 5.0 Hyper Hype‑Hypo‑Hypo
13 52 M S7 4.5 Iso Hypo Hype‑Hypo‑Hypo Hype‑Hypo‑Hypo
14 18 M S4 8.8 Hyper Hypo Hype‑Hype‑Hype Hype‑Hypo‑Hypo
15 36 M S2.3.4 12.8 Mix Mix Hype‑Hype‑Hypo Hype‑Hypo‑Hypo
16 38 M S6 3.7 Hypo iso Hype‑Iso‑Hypo Hype‑iso‑iso
17 28 F S6.7 8.0 Hyper Hypo Hype‑Iso‑Iso Hype‑Hype‑Hypo
18 44 M S4.5 4.4 Hypo Hypo Hype‑Hypo‑Hypo Hype‑Iso‑Hypo
Fig. 1 Contrast‑enhanced ultrasound (CEUS) and dynamic computed tomography (CT) images of HCA in a 41‑year‑old female (Case 3) dem‑
onstrate a hypoechoic (a) and hypointense (e) lesion to the surrounding liver. On contrast‑enhanced imaging, both modalities showed hyper‑
enhancement in the arterial phase (b, f). During the portal and late phases on CEUS, the lesion showed hypo‑enhancement (c, d). However, the 
lesion is iso‑enhanced (g, h)
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Enhancement level in vascular phases
On CEUS (n = 18) and dynamic CT (n = 14), all HCAs 
showed hyper-enhancement in the arterial phase. Dur-
ing the portal phase, 7 (7/18, 38.9 %) and 3 (8/14, 57.1 %) 
HCA showed hypo-enhancement on CEUS and dynamic 
CT, respectively. The washout continued on both imag-
ing modalities in the late phase, with 12 HCAs (12/18, 
66.7  %) on CEUS and 11 (11/14, 78.6  %) on CT show-
ing hypo-enhancement. On both CEUS and dynamic 
CT, there were five enhancement patterns: “hyper-hypo-
hypo”; “hyper-iso-hypo”; “hyper-iso-iso”; “hyper-hyper-
hyper”; and “hyper-hyper-hypo” (Fig.  1, Table  2). No 
statistical significance was found among enhancement 
types on CEUS and dynamic CT (all P > 0.05).
Specific features on contrast‑enhanced imaging
For the 18 HCAs with real-time CEUS, ten (10/18, 
55.6  %) showed centripetal filling in the arterial phase 
(Fig. 2), and 11 (61.1 %, 11/18) showed persistent periph-
eral rim enhancement in the arterial, portal and late 
phases. Five (5/18, 27.8 %) showed delayed central wash-
out in the portal or late phase. Three (3/18, 16.7 %) HCAs 
showed a central non-enhancing area that indicated a 
possible hemorrhage (Fig.  3). On CECT, 4 HCAs (4/14, 
28.6  %) showed a central non-enhancing hemorrhage 
area. Specific features were more frequently detected on 
CEUS than on dynamic CT (all P < 0.05), except for cen-
tral non-enhancement (P = 0.351) (Table 2). The vascu-
lar characteristics of the inflammatory HCAs and HNF-1 
alpha mutated HCAs were summarized in Table 3.
Discussion
It has been reported that HCAs are most common in 
women who have taken oral contraceptives for long 
periods of time (Baum et  al. 1973). The male-to-female 
ratio is 1:9, which is lower than that in our study (1:1). 
Our data coincide with reports from Asia (Kong et  al. 
Table 2 Imaging features on CEUS and dynamic CT
Hype hyper-enhancement, Iso iso-enhancement, Hypo hypo-enhancement




Hype‑Hype‑Hype 11.1 % (2/18) 7.1 % (1/14) 0.596
Hype‑Iso‑Iso 22.2 % (4/18) 21.4 % (3/14) 0.649
Hype‑Hype‑Hypo 11.1 % (1/18) 7.1 % (1/14) 0.692
Hype‑Iso‑Hypo 22.2 % (4/18) 14.3 % (2/14) 0.460




55.5 % (10/18) 0 0.001
Peripheral rim of 
persistent enhance‑
ment
61.1 % (11/18) 14.3 % (2/14) 0.009
Delayed central 
washout
27.8 % (5/18) 0 0.043
Central non‑enhanc‑
ing
16.7 % (3/18) 28.6 % (4/14) 0.351
Fig. 2 CEUS images in a 44‑year‑old male (Case 18) with HCA 
showed centripetal filling sign in the arterial phase. The lesion 
showed fine rim hyper‑enhancement at about 11 s in the early 
arterial phase (a, b), following a rapid centripetal homogenous hyper‑
enhancement of whole mass (c, d) 
Fig. 3 CEUS images in a 35‑year‑old female (Case 6) with HCA 
showed a central non‑enhancing area indicating possible hemor‑
rhage in the arterial phase
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2015; Hung et al. 2001) that suggested that a lower use of 
oral contraceptives in women and routine screening for 
hepatocellular carcinoma in men may result in a different 
male-to-female incidence ratio.
Several imaging modalities have been employed in 
the diagnosis of hepatic adenoma. However, no specific 
characteristics of HCAs can be identified on unenhanced 
imaging. Most HCAs are hypo-echoic or hyper-echoic on 
US and hypo-attenuated to the background liver paren-
chyma on CT. The mean size of HCAs in our study is 
larger than in previous reports (Zhu et  al. 2011; Ricci 
et al. 2008). Although larger lesions are at a higher risk of 
hemorrhage, the echogenicity in our study were homo-
geneous. Unlike the spoke-wheel flow pattern of FNH, 
short rod-like or periphery vessels on color Doppler 
cannot proved effective diagnostic information for HCA 
(Kong et al. 2015).
On enhanced imaging, most reports showed that 
45–60  % of HCAs were hyper-vascular in the arterial 
phase and hypo-enhanced in the portal or late phase. 
In our study, almost 70  % of lesions exhibited this 
enhancement pattern on CEUS and CECT, which can 
be encountered in HCC and hyper-enhancing metasta-
ses. Moreover, HCA with inhomogeneous enhancement 
is very difficult to discriminate from HCC in a non-cir-
rhosis liver. In case of this, future developments, such as 
elastography or new perfusion imaging, might be useful 
for classification of benign and malignant lesions (Wig-
germann et al. 2013; Jung et al. 2007). On the other hand, 
30.0 % of lesions on CEUS and 37.5 % on CECT appear 
to have sustained enhancement in later phases. Although 
this enhancement pattern suggests a benign tumor, a dif-
ficult differential diagnosis with FNH can also be encoun-
tered (Kong et al. 2015; Roche et al. 2015; Di Carlo et al. 
2010; Kim et  al. 2008; Dietrich et  al. 2005; Bartolozzi 
et al. 1997).
This diagnostic dilemma could be resolved by spe-
cifically characterizing the dynamic imaging features. 
According to previous studies, HCAs have some spe-
cial enhancement features, such as centripetal filling 
and persistent peripheral rim enhancement (Kim et  al. 
2008; Mathieu et  al. 1986). The specific centripetal fill-
ing sign, which was discovered on arteriography, was first 
reported on CEUS by Kim (Kim et al. 2008). This is the 
main differential feature with FNH, which is character-
ized by centrifugal filling and central scarring. The detec-
tion rate ranges from 20 to 94 % (Laumonier et al. 2012; 
Kim et  al. 2008; Kong et  al. 2015), which is consistent 
with the rate of 55.5 % in our study. Laumonier reported 
that the inflammatory subtype of HCA had a peripheral 
rim of sustained enhancement with a hypo-echoic central 
area (Laumonier et  al. 2012). In our study, this persis-
tent peripheral rim enhancement feature was detected in 
61.1 % of all HCAs and 50.0 % of inflammatory subtype 
on CEUS. The detection rate of this specific sign is lower 
in our cases because of the nine cases with unidentified 
subtype. However, none of the specific enhancement 
features discussed above was reported on CT. In our 
opinion, CEUS with inherent real-time scanning merit 
is better for display of those features. Although steato-
sis, calcification, necrosis and intro-tumor vessels on CT 
were reported in previous studies, these characteristics 
are not very sensitive (Burns and Wilson 2007; Hussain 
et al. 2006).
Our study has some limitations. First, it was a retro-
spective study based on small number of 18 cases, and 
only 14 of those were evaluated with CT. Second, as we 
focused on comparisons with CT, the problem of dif-
ferential diagnosis with FNH or HCC was neglected. 
Therefore, limited information had been provided for 
the diagnostic accuracy of CEUS for this issue. Moreo-
ver, some imaging features vary depending on the sub-
type of HCA and/or tumor size. In our study, we failed 
to describe the correlation between imaging patterns and 
subtypes because of limited cases.
In conclusion, our study demonstrated that the 
enhancement level in three vascular phases of HCA on 
CEUS was consistent with that on CECT. Compared with 
CECT, the real-time capability of CEUS is superior for 
characterizing dynamic centripetal filling, peripheral rim 
of persistent enhancement, and delayed central washout. 
In addition, because it is radiation-free, readily avail-
ability, and easy to use, CEUS has been suggested as the 
first line imaging tool to diagnose HCA. Further studies 
using larger sample sizes and comparisons with MRI are 
required.
Table 3 Imaging features of  inflammatory and  HNF1a-
inactivated subtype of HCA on CEUS






Hype‑Hype‑Hype 16.7 % (1/6) 0
Hype‑Iso‑Iso 33.3 % (2/6) 33.3 % (1/3)
Hype‑Hype‑Hypo 0 33.3 % (1/3)
Hype‑Iso‑Hypo 33.3 % (2/6) 0
Hype‑Hypo‑Hypo 16.7 % (1/6) 33.3 % (1/3)
Enhancement patterns
Centripetal arterial filling 33.3 % (2/6) 33.3 % (1/3)
Peripheral rim of persis‑
tent enhancement
50.0 % (3/6) 33.3 % (1/3)
Central non‑enhancing 33.3 % (2/6) 0
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